Portfolio company
Misti
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Misti develops customisable nebuliser technology to deliver medicines to the lungs of children and older adults with respiratory diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nebu-Flow
The company develops nebuliser technology for pharmaceutical partners to deliver biologic drugs and other formulations to the lungs of patients with respiratory disorders.
Sensory Cloud
Sensory Cloud develops aerosol therapies and salt-based mist products to enhance respiratory immunity and treat conditions for patients with chronic cough and airway irritation.
Miist Therapeutics
This company develops inhaled drug delivery devices providing rapid symptom relief for patients suffering from migraines or seeking smoking cessation.
Aetherus
Aetherus develops a handheld, non-invasive breathing device providing rapid relief from breathlessness for patients suffering from chronic obstructive pulmonary disease.
Softhale
This company develops propellant-free soft mist inhaler devices and pharmaceutical products for patients suffering from asthma and chronic obstructive pulmonary disease.
Volusense
The company develops non-invasive, mask-free respiratory monitoring systems used by neonatologists and paediatricians to evaluate lung function in preterm and term infants.
Aflo Analytics
This company develops a digital platform and connected sensor that monitors inhaler technique and adherence for patients with respiratory conditions and their clinicians.
Aluna
Aluna develops a digital spirometer and monitoring platform for patients and doctors to manage chronic respiratory conditions like asthma and COPD.
